Abstract A versatile and transition metal-free approach for the synthesis of a series of the novel 2,3,5,6-tetrahydro-11bH-[
Introduction
1,4-Benzoxazepines are of pharmacological interest due to their activity on the central nervous system, as enzyme inhibitors, or as analgesics and antitussives. 1 The 1,4-oxazepines are the parent core of medicinally important drugs like amoxapine, loxapine and sintamil. [2] [3] [4] It was reported that 1,4-oxazepine derivatives exhibit biological properties such as histone deacetylase inhibitors and antitumor activity. [5] [6] Most syntheses of 2,3,4,5-tetrahydro-1,4-benzoxazepines involve reduction of the carbonyl group(s) as in: 5-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepine 1 , 3-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepines 7,8 and 3,5-dioxo-2,3,4,5-tetrahydro-1,4-benzoxazepine 9, 10 or a double bond of 2,3-dihydro-1,4-benzothiazepine. 11 Alternatively, 2,3,4,5-tetrahydro-1,4-benzoxazepines are accessible by one of the following known benzoxazepine syntheses: (i) condensation of 2-aryloxyethylamines with 2-formylbenzoic acid to form aminonaphthalides followed by cyclization: (ii) rearrangement of methyl 2-(8-methoxy-2,3-dihydro-1,4benzoxazepin-5-yl)benzoate using Bischler-Napieralskiconditions; (iii) scandium or copper triflate-catalyzed acylaminoalkylation of α-methoxy-isoindolones with the formation of 1,4-benzoxazepines. [12] [13] [14] The derivatives of benzoxazepine and imidazole have been frequently synthesized and evaluated for their bioactivity. Some of the synthetic routes for fused benzoxazepine-imidazole derivatives have been reported. 12, 13, [15] [16] [17] In 1981, Levan et al. reported the isolation and characterization of unsubstituted 1,2,3,5,6,11b-hexahydroimidazo [1,2-d] [1, 4] benzoxazepine as a reaction byproduct. 18, 19 
Results and Discussion
In 2011, we reported a new, straightforward, high-yielding and convenient synthetic method for 1,2,3,5,6,11bhexahydroimidazo [1,2-d] [1, 4] benzoxazepines through a condensation of either aliphatic or aromatic 1,2diamines with 2-(2-bromoethoxy)benzaldehydes. 20 In continuation of our research program regarding generalization of this reaction as a useful method for the preparation of other [1, 4] benzooxazepines, a new series of [1, 4] benzoxazepines (7-25) have been prepared in high yield as shown in Scheme 1. They were obtained by the condensation of 2-aminoethanol, 3amino-1-propanol or 1,3-diaminopropane with 2-(2-bromoethoxy)benzaldehydes (1) (2) (3) (4) (5) (6) in presence of potassium carbonate in acetonitrile at reflux temperature. To the best of our knowledge, a general procedure for preparing these [1, 4] benzoxazepines has not been reported yet. Presence of anhydrous potassium carbonate and reflux temperature are essential conditions to obtain oxazepine products. Several experimental trials to condense 2-(2-bromoethoxy)benzaldehyde 1 with 2-aminophenol to obtain compound 26 failed and only a complex mixture of inseparable products was formed. Currently, other experimental conditions are under investigation in order to obtain compound 26 and its derivatives and the results will be published in due course. The compounds 7-25 were characterized by 1 H and 13 C NMR spectroscopy and high resolution mass spectroscopy. The mass spectra of prepared compounds displayed the correct molecular ion peaks for which the measured high resolution (HRMS) data are in good agreement with the calculated values. Spectral data, detailed in the experimental part, are consistent with the suggested structures. 1 H NMR spectra of compounds 7-13, as an example, have identical patterns in the chemical shift range δ ≈ 2.6-4.6 ppm. It shows seven sets of multiplets corresponding to magnetically non-equivalent methylene protons of benzoxazepine and imidazolidine rings. The signal at about δ 4.1 ppm counts for two protons. For compounds 7-19, the signals of the proton and the carbon atoms of CHNN segment show up as sharp singlet signals around δ = 5 ppm and 90 ppm, respectively. On the other hand, these two signals for compounds 20-25 show up around 4.6 ppm and 70 ppm. Consequently, these two signals can be considered as strong evidence for the formation of the tricyclic product. Crystals of compound 7 were obtained from ethylacetate. The derived molecular structure of the heterotricyclic scaffold is shown in Figure 1 . Compound 7 crystallizes in orthorhombic P2 1 2 1 2 1 space group. The two heterocyclic moieties are not planar, the mean deviation of atoms from the plane of the specified atom of the heterocyclic ring are 0.1559 Å and 0.2654 Å for the five and seven membered rings. A plausible reaction mechanism that can be proposed for the formation of tricyclic scaffolds [1, 4] benzoxazepines is shown in Scheme 2. As shown, the initial event is the condensation of the amino group with the aldehyde group to form imine 27. The intermediate 28 is produced from nucleophilic attack of the hydroxyl group (or another amino group) on the imine site of 27. Intramolecular nucleophilic substation reaction between cyclic secondary amine and alkylbromide produce the tricyclic scaffolds [1, 4] benzoxazepines 29. Scheme 2. Proposed mechanism for the formation of tricyclic [1, 4] benzoxazepine scaffolds.
Conclusions
In summary, the condensation of 2-aminoethanol or 3-amino-1-propanol or 1,3-diaminopropane with a 2-(2bromoethoxy)benzaldehydes (1) (2) (3) (4) (5) (6) in acetonitrile in the presence of anhydrous potassium carbonate at reflux temperature provides a new, facile and efficient route for the synthesis of 2,3,5,6-tetrahydro-11bH- [1, 3] [1, 4] benzoxazepine and their derivatives in very good yields. The advantages of this method are high yield, readily available starting materials, simple procedure, and a straightforward purification of the products. Biological activities such as antibacterial, antifungal, cytotoxicity for these new compounds are currently under investigation and the results will be published in due course.
Experimental Section
General. Silica gel 60 for column chromatography Fluka. The progress of reactions was monitored by means of thin-layer chromatography (TLC), carried out on TLC sheets that were visualized under UV light (where appropriate). On the other hand, preparative thick layer (0.25 mm) chromatography was performed on silica gel glass plates (60 F-254, 20 cm × 20 cm, Fluka). Melting points were determined on a Stuart scientific melting point apparatus in open capillary tubes and were uncorrected. 1 H NMR and 13 C NMR spectra were recorded on a 500 MHz spectrometer (Bruker DPX-500) with TMS as the internal standard. Chemical shifts are expressed in (δ) are given in ppm, whereas J-values for 1 H-1 H coupling constants are given in Hertz. Highresolution mass spectra (HRMS) were obtained (in positive/or negative ion mode) using electron spray ion trap (ESI) technique with a Bruker APEX-4 (7 Tesla) instrument. Samples were dissolved in acetonitrile, diluted with a spray solution (methanol/water 1:1 v/v + 0.1% formic acid), and infused using a syringe pump with a flow rate of 2 µL/min. External calibration was conducted using arginine cluster in a mass range m/z 175-871. 2-(2-Bromoethoxy)benzaldehydes 1 and 6 were prepared according to the literature. 20,21 2-(2-Bromoethoxy)benzaldehydes 2-5 were prepared as 1 and 6 to give after column chromatographic purification using ethyl acetate-hexane (1:4) the following pure products: 5-Chloro-2-(2-bromoethoxy)benzaldehyde (2) . Pale-yellow solid; yield 82% ; mp 44-45 o C; 1 General procedure for the preparation of [1,4]benzoxazepines 7-25. In a 100 mL two-necked round bottom flask equipped with a magnetic stirrer bar, a reflux condenser and a gas line to maintain a nitrogen atmosphere, 2-(2-bromoethoxy)benzaldehyde (2 mmol) and anhydrous K 2 CO 3 (0.55 g, 4 mmol) were suspended in anhydrous CH 3 CN (100 mL). To this well-stirred solution at room temperature was added a solution of 2-aminoethanol or 3-amino-1-propanol or 1,3-diaminopropane (2 mmol) in dry CH 3 CN (10 mL) dropwise. The reaction mixture was refluxed with stirring for 24h. The reaction mixture was filtered, and the solvent was evaporated. The crude product was purified by column chromatography or thin layer chromatography using a solvent system indicated for individual reaction. 2,3,5,6-Tetrahydro-11bH-[1,3]oxazolo[3,2-d][1,4]benzoxazepine (7) . The crude product was purified by column chromatography using CHCl 3 :CH 3 OH (9:1) to give light yellow solid; yield 78%; mp 73-74.5 o C; 1 10-Bromo-2,3,5,6-tetrahydro-11bH-[1,3]oxazolo[3,2-d][1,4]benzoxazepine (9) . The crude product was purified by column chromatography using CHCl 3 :CH 3 OH (9:1) to give light yellow solid; yield 82%; mp 74-75 o C; 1 10-Methoxy-2,3,5,6-tetrahydro-11bH-[1,3]oxazolo[3,2-d][1,4]benzoxazepine (11) . The crude product was purified by column chromatography using CHCl 3 :CH 3 OH (9:1) to give yellow semi-solid; yield 87%; 1 3,5,6,13b-Tetrahydro-2H-naphtho[2,3-f]oxazolo[3,2-d][1,4]oxazepine (12) . The crude product was purified by column chromatography using CHCl 3 :CH 3 OH (9:1) to give light red solid; yield 84%; mp 73-74 o C; 1 3, 117.3, 125.0, 126.3, 126.9, 128.2, 130.6, 133.4, 133.9, 155.6; HRMS (ESI) 3,4,6,7-Tetrahydro-2H,12bH-[1,3]oxazino[3,2-d][1,4]benzoxazepine (14) . The crude product was purified by TLC using ethylacetate:CH 3 OH (7:3); yellow semi-solid; yield 81%; 1 Bromo-3,4,6,7-tetrahydro-2H,12bH-[1,3]oxazino[3,2-d][1,4]benzoxazepine (16) . The crude product was purified by TLC using CHCl 3 :CH 3 OH (9:1); yellow semi-solid; yield 73%; 1 2,3,4,6,7,14b-Hexahydronaphtho[2,3-f][1,3]oxazino[3,2-d][1,4]oxazepine (19) . The crude product was purified by TLC using ethylacetate:CH 3 OH (8:2); yellow solid; yield 79%; mp 114-115 o C; 1 
